This article unpacks the latest scientific findings and their implications for the future of cancer treatment.

An early-stage study has found that a common chemotherapy drug disrupts lymphatic cells in the tissue surrounding the brain.

Detailed price information for Bayer Aktienges ADR (BAYRY) from The Globe and Mail including charting and trades.

A chef who was diagnosed with an aggressive form of breast cancer, which means he will have chemotherapy "for the rest of his ...

Phase 3 ARENSENS clinical trial results were presented at JADPRO 2025, indicating darolutamide plus ADT improved rPFS in prostate cancer.

NICE recommendation of darolutamide plus hormone therapy for metastatic prostate cancer offers around 6000 patients in ...

Jennifer Munson’s decade-long study in Roanoke reveals that chemo drugs damage the brain’s waste-clearing vessels — a breakthrough that could lead to treatments for “chemo brain” and other ...

After visiting his GP, he was referred to hospital for further testing, where he said he had to push for “progress and ...

A new study suggests that memory problems and difficulty concentrating after chemotherapy may stem from impaired lymphatic-system drainage caused by cancer drugs. Cancer is already a difficult ...

Imfinzi plus FLOT chemotherapy significantly improves overall survival in resectable G/GEJ adenocarcinoma compared to placebo plus FLOT. The MATTERHORN trial showed consistent survival benefits across ...

Cancer is a challenging enough diagnosis, but many patients are dealt a second blow, even as they heal: "chemo brain." Also called "brain fog," this mix of cognitive issues—memory problems, struggling ...